tiprankstipranks
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
US Market
ELTX
Elicio Therapeutics
RESEARCH TOOLSreports
Want to see ELTX full AI Analyst Report?

Elicio Therapeutics (ELTX) Income Statement

227 Followers

Elicio Therapeutics Income Statement

Last quarter (Q4 2025), Elicio Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Elicio Therapeutics's net income was $-7.72M. See Elicio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 28.31M
Gross Profit
$ -1.13M$ -1.18M$ -1.17M$ -1.06M$ 27.08M
Operating Expenses
$ 36.59M$ 43.81M$ 34.58M$ 22.68M$ 66.39M
Depreciation and Amortization
$ 1.13M$ 1.18M$ 1.17M$ 1.06M$ 801.00K
EBITDA
$ -36.59M$ -50.27M$ -32.97M$ -23.55M$ -51.92M
Operating Income
$ -37.71M$ -44.99M$ -35.74M$ -23.73M$ -39.31M
Other Income/Expenses
$ -1.86M$ -6.91M$ 550.00K$ -4.47M$ -15.27M
Pretax Income
$ -39.57M$ -51.90M$ -35.20M$ -28.21M$ -54.57M
Net Income
$ -39.57M$ -51.90M$ -35.20M$ -28.21M$ -26.40M
Per Share Metrics
Basic EPS
$ -2.58$ -4.25$ -6.96$ -9.10$ -19.32
Diluted EPS
$ -2.58$ -4.25$ -6.96$ -9.10$ -19.32
Weighted Average Shares Outstanding
 15.31M 12.20M 5.06M 3.10M 3.20M
Weighted Average Shares Outstanding (Diluted)
 15.31M 12.20M 5.06M 3.10M 3.20M
Currency in USD

Elicio Therapeutics Earnings and Revenue History